Effects of repeated amphetamine treatment on regional GABAA receptor binding

The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1999-04, Vol.825 (1-2), p.180-182
Hauptverfasser: GRUEN, R. J, STOKER, S, FRIEDHOFF, A. J, BRADBERRY, C. W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 182
container_issue 1-2
container_start_page 180
container_title Brain research
container_volume 825
creator GRUEN, R. J
STOKER, S
FRIEDHOFF, A. J
BRADBERRY, C. W
description The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.
doi_str_mv 10.1016/S0006-8993(99)01150-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69713876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69713876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</originalsourceid><addsrcrecordid>eNpNkE1PhDAQhhujcdfVn6DhYIwe0A6FQo-4WT-STTyo52Yow4qBgi178N_LfkQ9Td7JMx95GDsHfgsc5N0r51yGmVLiWqkbDpDwUB6wKWRpFMoo5ods-otM2In3n2MUQvFjNgEegYQsmbLloqrIDD7oqsBRTzhQGWDbf9CAbW0pGNzYa8kOQWdHYlV3FpvgMb_P8zEa6ofOBUVty9quTtlRhY2ns32dsfeHxdv8KVy-PD7P82VooiiTYUGliWWCsZBlIRUAzwBBoDIFpiAAMSsMlmmiYohQIJgyprRKpISEqEzFjF3t9vau-1qTH3Rbe0NNg5a6tddSjWuyVI5gsgON67x3VOne1S26bw1cbzTqrUa9caSV0luNejN3sT-wLloq_03tvI3A5R5Ab7CpHFpT-z9u_D2JMvEDZCZ6Lw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69713876</pqid></control><display><type>article</type><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</creator><creatorcontrib>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</creatorcontrib><description>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(99)01150-6</identifier><identifier>PMID: 10216185</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier</publisher><subject>Adrenergic Agents - pharmacology ; Amphetamine - pharmacology ; Animals ; Biological and medical sciences ; Brain Chemistry - drug effects ; Cerebellum - chemistry ; GABA Antagonists - pharmacology ; Hypothalamus - chemistry ; Locomotion - physiology ; Male ; Medical sciences ; Neostriatum - chemistry ; Neuropharmacology ; Pharmacology. Drug treatments ; Prefrontal Cortex - chemistry ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Pyridazines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, GABA-A - metabolism ; Receptors, GABA-A - physiology ; Tritium</subject><ispartof>Brain research, 1999-04, Vol.825 (1-2), p.180-182</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright 1999 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</citedby><cites>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1759528$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10216185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GRUEN, R. J</creatorcontrib><creatorcontrib>STOKER, S</creatorcontrib><creatorcontrib>FRIEDHOFF, A. J</creatorcontrib><creatorcontrib>BRADBERRY, C. W</creatorcontrib><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</description><subject>Adrenergic Agents - pharmacology</subject><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain Chemistry - drug effects</subject><subject>Cerebellum - chemistry</subject><subject>GABA Antagonists - pharmacology</subject><subject>Hypothalamus - chemistry</subject><subject>Locomotion - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neostriatum - chemistry</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prefrontal Cortex - chemistry</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, GABA-A - metabolism</subject><subject>Receptors, GABA-A - physiology</subject><subject>Tritium</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1PhDAQhhujcdfVn6DhYIwe0A6FQo-4WT-STTyo52Yow4qBgi178N_LfkQ9Td7JMx95GDsHfgsc5N0r51yGmVLiWqkbDpDwUB6wKWRpFMoo5ods-otM2In3n2MUQvFjNgEegYQsmbLloqrIDD7oqsBRTzhQGWDbf9CAbW0pGNzYa8kOQWdHYlV3FpvgMb_P8zEa6ofOBUVty9quTtlRhY2ns32dsfeHxdv8KVy-PD7P82VooiiTYUGliWWCsZBlIRUAzwBBoDIFpiAAMSsMlmmiYohQIJgyprRKpISEqEzFjF3t9vau-1qTH3Rbe0NNg5a6tddSjWuyVI5gsgON67x3VOne1S26bw1cbzTqrUa9caSV0luNejN3sT-wLloq_03tvI3A5R5Ab7CpHFpT-z9u_D2JMvEDZCZ6Lw</recordid><startdate>19990417</startdate><enddate>19990417</enddate><creator>GRUEN, R. J</creator><creator>STOKER, S</creator><creator>FRIEDHOFF, A. J</creator><creator>BRADBERRY, C. W</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990417</creationdate><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><author>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adrenergic Agents - pharmacology</topic><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain Chemistry - drug effects</topic><topic>Cerebellum - chemistry</topic><topic>GABA Antagonists - pharmacology</topic><topic>Hypothalamus - chemistry</topic><topic>Locomotion - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neostriatum - chemistry</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prefrontal Cortex - chemistry</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, GABA-A - metabolism</topic><topic>Receptors, GABA-A - physiology</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GRUEN, R. J</creatorcontrib><creatorcontrib>STOKER, S</creatorcontrib><creatorcontrib>FRIEDHOFF, A. J</creatorcontrib><creatorcontrib>BRADBERRY, C. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GRUEN, R. J</au><au>STOKER, S</au><au>FRIEDHOFF, A. J</au><au>BRADBERRY, C. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of repeated amphetamine treatment on regional GABAA receptor binding</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1999-04-17</date><risdate>1999</risdate><volume>825</volume><issue>1-2</issue><spage>180</spage><epage>182</epage><pages>180-182</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier</pub><pmid>10216185</pmid><doi>10.1016/S0006-8993(99)01150-6</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1999-04, Vol.825 (1-2), p.180-182
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_69713876
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic Agents - pharmacology
Amphetamine - pharmacology
Animals
Biological and medical sciences
Brain Chemistry - drug effects
Cerebellum - chemistry
GABA Antagonists - pharmacology
Hypothalamus - chemistry
Locomotion - physiology
Male
Medical sciences
Neostriatum - chemistry
Neuropharmacology
Pharmacology. Drug treatments
Prefrontal Cortex - chemistry
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Pyridazines - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, GABA-A - metabolism
Receptors, GABA-A - physiology
Tritium
title Effects of repeated amphetamine treatment on regional GABAA receptor binding
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T18%3A47%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20repeated%20amphetamine%20treatment%20on%20regional%20GABAA%20receptor%20binding&rft.jtitle=Brain%20research&rft.au=GRUEN,%20R.%20J&rft.date=1999-04-17&rft.volume=825&rft.issue=1-2&rft.spage=180&rft.epage=182&rft.pages=180-182&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(99)01150-6&rft_dat=%3Cproquest_cross%3E69713876%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69713876&rft_id=info:pmid/10216185&rfr_iscdi=true